Malignancies in sickle cell disease patients treated with hydroxyurea.
Ferster
Alina
A
Sariban
Eric
E
Meuleman
Nathalie
N
D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000986:Antisickling Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects*; D015473:Leukemia, Promyelocytic, Acute / Q000139:chemically induced*
D000986:Antisickling Agents; D006918:Hydroxyurea